Extended reports
HLA-DRB1 alleles associated with polymyalgia rheumatica in
northern Italy: correlation with disease severity
a Servizio di
Reumatologia, Arcispedale S Maria Nuova, Reggio Emilia, Italy, b Laboratorio Centralizzato, Settore Tipizzazione
Tissutale, Ospedale S Orsola-Malpighi, Bologna, Italy, c Cattedra di Biometria e Statistica Medica,
Istituto di Igiene, Università di Modena, Italy, d Unità
Reumatologica, Ospedale di Prato, Prato, Italy, e Unità di Reumatologia, Ospedale S Carlo,
Potenza, Italy
Correspondence to: Dr C Salvarani, Servizio di Reumatologia, Azienda Ospedaliera Arcispedale S Maria Nuova, V le Umberto 1 N50, 42100 Reggio Emilia, Italy.
Accepted for publication 15 February 1999
OBJECTIVE
To examine
the association of HLA-DRB1 alleles with polymyalgia rheumatica (PMR)
in a Mediterranean country and to explore the role of HLA-DRB1 genes in
determining disease severity.
METHODS
A five year
prospective follow up study of 92 consecutive PMR patients diagnosed by
the secondary referral centre of rheumatology of Reggio Emilia, Italy
was conducted. HLA-DRB1 alleles were determined in the 92 patients, in
29 DR4 positive rheumatoid arthritis (RA) patients, and in 148 controls
from the same geographical area by polymerase chain reaction
amplification and oligonucleotide hybridisation.
RESULTS
No significant
differences were observed in the frequencies of HLA-DRB1 types and in
the expression of HLA-DRB 70-74 shared motif between PMR and controls.
The frequency of the patients with double dose of epitope was low and
not significantly different in PMR and in controls. No significant
differences in the distribution of HLA-DR4 subtypes were observed
between DR4+ PMR, DR+ RA, and DR4+ controls. Results of the univariate
analysis indicated that an erythrocyte sedimentation rate (ESR) at
diagnosis > 72 mm 1st h, the presence of HLA-DR1, DR10, rheumatoid
epitope, and the type of rheumatoid epitope were significant risk
factors associated with relapse/recurrence. Cox proportional hazards
modelling identified two variables that independently increased the
risk of relapse/recurrence: ESR at diagnosis > 72 mm 1st h (RR=1.5)
and type 2 (encoded by a non-DR4 allele) rheumatoid epitope (RR=2.7).
CONCLUSION
These data
from a Mediterranean country showed no association of rheumatoid
epitope with PMR in northern Italian patients. A high ESR at diagnosis
and the presence of rheumatoid epitope encoded by a non-DR4 allele are
independent valuable markers of disease severity.
© 1999 by Annals of the Rheumatic Diseases
This article has been cited by other articles:
-
Pease, C. T., Haugeberg, G., Montague, B., Hensor, E. M. A., Bhakta, B. B., Thomson, W., Ollier, W. E. R., Morgan, A. W.
(2009). Polymyalgia rheumatica can be distinguished from late onset rheumatoid arthritis at baseline: results of a 5-yr prospective study. Rheumatology (Oxford)
48: 123-127
[Abstract] [Full Text] -
Salvarani, C., Macchioni, P., Manzini, C., Paolazzi, G., Trotta, A., Manganelli, P., Cimmino, M., Gerli, R., Catanoso, M. G., Boiardi, L., Cantini, F., Klersy, C., Hunder, G. G.
(2007). Infliximab plus Prednisone or Placebo plus Prednisone for the Initial Treatment of Polymyalgia Rheumatica: A Randomized Trial. ANN INTERN MED
146: 631-639
[Abstract] [Full Text] -
Caporali, R., Cimmino, M. A., Ferraccioli, G., Gerli, R., Klersy, C., Salvarani, C., Montecucco, C., for the Systemic Vasculitis Study Group of the Ita,
(2004). Prednisone plus Methotrexate for Polymyalgia Rheumatica: A Randomized, Double-Blind, Placebo-Controlled Trial. ANN INTERN MED
141: 493-500
[Abstract] [Full Text] -
Salvarani, C., Cantini, F., Boiardi, L., Hunder, G. G.
(2002). Polymyalgia Rheumatica and Giant-Cell Arteritis. NEJM
347: 261-271
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
